Minners Jan, McLeod Christopher J, Sack Michael N
Hatter Institute for Cardiology Research and MRC Inter-University Cape Heart Group, University of Cape Town Medical School, Cape Town, South Africa.
Cardiovasc Res. 2003 Jul 1;59(1):1-6. doi: 10.1016/s0008-6363(03)00337-7.
Ischemic preconditioning is a powerful biologic phenomenon that activates innate cell survival programs to protect the heart from ischemic injury. The preponderance of research into classical ischemic preconditioning has focused on signaling pathways orchestrating cardioprotection. Conceptually classified into triggers, mediators and end effectors of preconditioning multiple distinct signaling pathways appear to 'converge' on the mitochondria possibly via activation of the mitochondrial ATP-sensitive potassium (mK(ATP)) channel. The mechanisms by which mK(ATP) channel activation induces preconditioning are incompletely elucidated but include perturbations of mitochondrial architecture and function. Since evidence invoking the mK(ATP) channel has almost exclusively been based on studies using diazoxide and 5-hydroxydecanote the finding that these two compounds have mitochondrial effects independent of the mK(ATP) channel has initiated a controversy regarding the exclusivity of this particular channel in preconditioning. A concerted effort to characterize the mitochondrial phenotype is important to advance our understanding of the mechanistic events that underlie the robust cardioprotective phenotype unmasked by preconditioning. The purpose of this review is to collate the information available on mitochondrial biology associated with classical preconditioning, to delineate the distinct temporal presentation of these mitochondrial perturbations, to reassess the role of the mitochondrial K(ATP) channel and to propose a working model integrating the mitochondrial adaptations into the biology driving this cyto-protective phenotype.
缺血预处理是一种强大的生物学现象,它激活先天的细胞存活程序以保护心脏免受缺血性损伤。对经典缺血预处理的研究主要集中在协调心脏保护作用的信号通路。从概念上可分为预处理的触发因素、介质和终末效应器,多种不同的信号通路似乎可能通过激活线粒体ATP敏感性钾(mK(ATP))通道而在“线粒体”上“汇聚”。mK(ATP)通道激活诱导预处理的机制尚未完全阐明,但包括线粒体结构和功能的扰动。由于几乎所有引用mK(ATP)通道的证据都基于使用二氮嗪和5-羟基癸酸的研究,因此这两种化合物具有独立于mK(ATP)通道的线粒体效应这一发现引发了关于该特定通道在预处理中排他性的争议。齐心协力表征线粒体表型对于推进我们对预处理所揭示的强大心脏保护表型背后的机制事件的理解很重要。本综述的目的是整理与经典预处理相关的线粒体生物学方面的现有信息,描绘这些线粒体扰动的不同时间表现,重新评估线粒体K(ATP)通道的作用,并提出一个将线粒体适应性整合到驱动这种细胞保护表型的生物学过程中的工作模型。